Related Experiment Video
Updated: Feb 14, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
Published on: May 16, 2025
Reversible Parkinsonism With Recovery of 123 I-Ioflupane DAT‑SPECT After Treating Rheumatoid Meningitis
Taro Bannai1, Koshiro Yoshii, Minako Yamada
1Department of Neurology, Tokyo Teishin Hospital, Tokyo, Japan.
Abstract:
We report reversible parkinsonism in rheumatoid meningitis with normalization of 123 I-ioflupane DAT-SPECT after immunotherapy. A previously independent 42-year-old man presented with fever, encephalopathy, focal seizures, and akinetic-rigid parkinsonism. MRI showed pachy/leptomeningeal enhancement with sulcal FLAIR hyperintensity; CSF revealed lymphocytic pleocytosis and elevated protein with negative infectious studies. High-dose intravenous methylprednisolone followed by taper led to rapid improvement. Baseline DAT-SPECT showed reduced striatal uptake, which recovered on follow-up in parallel with symptom resolution and reductions in intrathecal anti-CCP index and CSF IL-6, supporting autoimmune, reversible presynaptic dopaminergic dysfunction.
Insights
Rheumatoid meningitis can cause reversible parkinsonism and brain changes. Immunotherapy effectively treated these symptoms, normalizing brain imaging and restoring function.
Area of Science:
- Neurology
- Immunology
- Radiology
Background:
- Rheumatoid meningitis is a rare complication of rheumatoid arthritis.
- Parkinsonism can be a presenting symptom of central nervous system involvement in autoimmune diseases.
Purpose of the Study:
- To report a case of reversible parkinsonism secondary to rheumatoid meningitis.
- To investigate the utility of 123I-ioflupane DAT-SPECT in assessing dopaminergic dysfunction in this condition.
Main Methods:
- Case report of a 42-year-old male with fever, encephalopathy, seizures, and parkinsonism.
- Neuroimaging including MRI and 123I-ioflupane DAT-SPECT.
- Cerebrospinal fluid (CSF) analysis.
- Treatment with high-dose intravenous methylprednisolone and subsequent taper.
Main Results:
- MRI revealed pachy/leptomeningeal enhancement and sulcal FLAIR hyperintensity.
- CSF showed lymphocytic pleocytosis and elevated protein with negative infectious studies.
- Baseline 123I-ioflupane DAT-SPECT demonstrated reduced striatal uptake.
- Symptoms resolved rapidly following immunotherapy, with normalization of DAT-SPECT findings on follow-up.
- Reductions in intrathecal anti-CCP index and CSF IL-6 correlated with clinical improvement.
Conclusions:
- Reversible parkinsonism can occur in the context of rheumatoid meningitis.
- Immunotherapy is an effective treatment, leading to clinical and radiological improvement.
- 123I-ioflupane DAT-SPECT can track reversible presynaptic dopaminergic dysfunction in autoimmune meningitis.
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Reversible and Irreversible Processes
Diode: Reverse bias
Muscle Recovery and Fatigue

